Delaware
|
|
001-33749
|
|
26-0500600
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S.
Employer
Identification
No.)
|
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR
230.425)
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR
240.14d-2(b))
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR
240.13e-4(c))
|
Exhibit No.
|
|
Description
|
99.1
|
|
Audited
Financial Statements
|
Date:
October 26, 2007
|
|
NRDC
ACQUISITION CORP.
|
||
|
By:
|
|
/s/
Richard A. Baker
|
|
|
|
Richard
A. Baker
|
||
|
|
Chief
Executive Officer
|
|
|
October
23, 2007
|
|
|
ASSETS
|
|
|
|
|
Cash
|
|
$
|
432,140
|
|
Investments
held in trust
|
|
|
391,966,881
|
|
Investments
held in trust from underwriter
|
|
|
14,490,000
|
|
Total
assets
|
|
$
|
406,889,021
|
|
LIABILITIES
AND STOCKHOLDERS’ EQUITY
|
|
|
|
|
Current
liabilities:
|
|
|
|
|
Accrued
expenses
|
|
$
|
2,182
|
|
Accrued
offering costs
|
|
|
268,040
|
|
Deferred
underwriting fee
|
|
|
14,490,000
|
|
Total
liabilities
|
|
|
14,760,222
|
|
Common
Stock, subject to possible conversion of 12,419,999 shares at conversion
value
|
|
|
117,590,055
|
|
Commitments
(Note 5)
|
|
|
|
|
Stockholders’
equity
|
|
|
|
|
Preferred
stock, $.0001 par value Authorized 5,000 shares; none issued and
outstanding
|
|
|
—
|
|
Common
stock, $.0001 par value Authorized 106,000,000 shares
Issued
and outstanding 51,750,000
shares (which includes 12,419,999 shares subject to possible
conversion)
|
|
|
5,175
|
|
Additional
paid-in capital
|
|
|
274,535,751
|
|
Deficit
accumulated during the development stage
|
|
|
(2,182)
|
|
Total
stockholders’ equity
|
|
|
274,538,744
|
|
Total
liabilities and stockholders’ equity
|
|
$
|
406,889,021
|
|
Filing
Fees
|
|
$
|
731
|
|
General/Administrative
Services
|
1,451
|
|||
Net
loss
|
|
$
|
(2,182)
|
|
Weighted
average shares outstanding – basic and diluted
|
|
|
10,751,942
|
|
Net
loss per share – basic and diluted
|
|
$
|
—
|
|
Common
Stock
|
|||||||||||||||||||
|
Shares
|
Amount
|
Additional
paid-in
capital
|
Deficit
Accumulated
During
the
Development Stage
|
Stockholders’
Equity
|
|||||||||||||||
Issuance
of units to Founders on July 13, 2007 at approximately $0.002 per
share
|
10,350,000
|
$ |
1,035
|
$ |
23,965
|
|
$ |
25,000
|
||||||||||||
Sale
of Private Placement Warrants
|
8,000,000
|
|
8,000,000
|
|||||||||||||||||
Sale
of 41,400,000 units through public offering (net of underwriter’s discount
and offering expenses) including 12,419,999 shares subject to possible
conversion
|
41,400,000
|
4,140
|
384,101,841
|
|
384,105,981
|
|||||||||||||||
Proceeds
subject to possible conversion
|
(117,590,055 | ) |
|
(117,590,055 | ) | |||||||||||||||
Net
Loss
|
(2,182 | ) | (2,182 | ) | ||||||||||||||||
Balance
at October 23, 2007
|
51,750,000
|
$ |
5,175
|
$ |
274,535,751
|
$ | (2,182 | ) | $ |
274,538,744
|
|
|
|
|
|
Cash
flows from operating activities
|
|
|
|
|
Net
loss
|
|
$
|
(2,182)
|
|
Increase
in accrued expenses
|
|
|
2,182
|
|
Net
cash used in operating activities
|
|
|
—
|
|
|
|
|
|
|
Cash
flows from investing activities
|
|
|
|
|
Investments
placed in trust
|
|
|
(406,456,881)
|
|
Net
cash used in investing activities
|
|
|
(406,456,881)
|
|
|
|
|
|
|
Cash
flows from financing activities
|
|
|
|
|
Proceeds
from sale of units to public
|
|
|
414,000,000
|
|
Proceeds
from private placement of warrants
|
|
|
8,000,000
|
|
Proceeds
from sale of units to Founders
|
|
|
25,000
|
|
Proceeds
from notes payable to affiliates of Founders
|
|
|
200,000
|
|
Repayment
of notes payable to affiliates of Founders
|
|
|
(200,000)
|
|
Payment
of offering costs
|
|
|
(15,135,979)
|
|
Net
cash provided by financing activities
|
|
|
406,889,021
|
|
Net
increase in cash
|
|
|
432,140
|
|
Cash
at beginning of period
|
|
|
—
|
|
Cash
at end of period
|
|
$
|
432,140
|
|
|
|
|
|
|
Supplemental
disclosure of noncash financing activities:
|
|
|
|
|
Accrual
of deferred offering costs
|
|
$
|
268,040
|
|
Accrual
of deferred underwriting fee
|
|
$
|
14,490,000
|
|
Note
1
|
Organization
and Business Operations
|
Note
2
|
Summary
of Significant Accounting
Policies
|
Note
3
|
Initial
Public Offering
|
Note
4
|
Notes
Payable to Affiliate
|
Note
5
|
Commitments
|
Note
6
|
Preferred
Stock
|
Note
7
|
Common
Stock
|